BOOTS UK LIMITED
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Drugs, Drug Proprietaries, and Druggists' Sundries, Miscellaneous General Merchandise Stores, Drug Stores and Proprietary Stores), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about BOOTS UK LIMITED
Live alerts from global media, monitored by Business Radar
2025-01-19 (windsorexpress.co.uk)
Remember When: 'Explosive debate' at anti-poll tax meeting - Photo 1 of 1 - Windsor Express
This week's Remember When looks back at a packed meeting where furious residents voiced their opposition to the poll tax.
Read more
2025-01-18 (sloughexpress.co.uk)
Remember When: 'Explosive debate' at anti-poll tax meeting - Photo 1 of 1 - Slough Express
This week's Remember When looks back at a packed meeting where furious residents voiced their opposition to the poll tax.
Read more
2014-07-19 (forbes.com)
Can Anything Stop Drug Companies From Fleeing The U.S. Tax System?
Friday morning, after five spurned bids, AbbVie, the North Chicago-based pharmaceutical giant finally closed in on a deal to buy Irish drugmaker Shire for $54 billion. One key consequence of the deal: AbbVie will change its tax domicile from Illinois to the U.K., reducing its tax rate. The deal, the largest [...]
Read more
2014-07-19 (forbes.com)
Can Anything Stop Drug Companies From Fleeing The U.S. Tax System?
Friday morning, after five spurned bids, AbbVie, the North Chicago-based pharmaceutical giant finally closed in on a deal to buy Irish drugmaker Shire for $54 billion. One key consequence of the deal: AbbVie will change its tax domicile from Illinois to the U.K., reducing its tax rate. The deal, the largest [...]
Read more
2014-07-19 (forbes.com)
Can Anything Stop Drug Companies From Fleeing The U.S. Tax System?
Friday morning, after five spurned bids, AbbVie, the North Chicago-based pharmaceutical giant finally closed in on a deal to buy Irish drugmaker Shire for $54 billion. One key consequence of the deal: AbbVie will change its tax domicile from Illinois to the U.K., reducing its tax rate. The deal, the largest [...]
Read more